Pre-habilitation Multicomponent Lifestyle Program for Patients Undergoing Ablation for Atrial Fibrillation

Mayo Clinic1 site in 1 country40 target enrollmentSeptember 2024

ConditionsAtrial Fibrillation

Overview

Phase: N/A
Intervention: Not specified
Conditions: Atrial Fibrillation
Sponsor: Mayo Clinic
Enrollment: 40
Locations: 1
Primary Endpoint: Number of Cardiac Rehab Sessions Attended
Status: Withdrawn
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to examine the impact of a comprehensive lifestyle intervention, including cardiac rehabilitation, prior to catheter ablation (a procedure to stop abnormal electrical signals in the heart), on Atrial Fibrillation (AF)-related symptoms.

Registry

clinicaltrials.gov

Start Date

September 2024

End Date

August 2026

Last Updated

last year

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Mayo Clinic

Responsible Party

Principal Investigator

Amanda R. Bonikowske

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

•Paroxysmal or persistent atrial fibrillation.
•Planned elective catheter ablation of AF.

Exclusion Criteria

•Prior catheter ablation.
•Presence of pacemaker/ICD.
•Longstanding persistent AF.
•Uncontrolled AF (including poor rate control or tachycardia-mediated cardiomyopathy requiring urgent cardioversion/ablation at the clinician's assessment).

Outcomes

Primary Outcomes

Number of Cardiac Rehab Sessions Attended

Time Frame: 12 weeks

Number of cardiac rehab sessions attended during the 12-week multicomponent lifestyle intervention program.

Secondary Outcomes

Change in weight loss(Baseline, 12 weeks)
Number of subjects with Atrial Fibrillation (AF) recurrence(1 year)
Change in exercise capacity(Baseline, 12 weeks)
Change in Atrial Fibrillation (AF) Symptom severity(Baseline, 12 weeks, 6 months, 1 year)